Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Range Cancer Therapeutics ETF
(NQ:
CNCR
)
9.020
UNCHANGED
Last Price
Updated: 4:15 PM EDT, May 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
9.020
Bid (Size)
7.800 (1)
Ask (Size)
19.92 (4)
Prev. Close
9.020
Today's Range
9.020 - 9.020
52wk Range
9.020 - 9.020
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Did CANF Stock Soar 40% In Pre-Market Today?
↗
March 04, 2026
The company said its trial to study the treatment of patients with advanced pancreatic ductal adenocarcinoma met its primary endpoint.
Via
Stocktwits
IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers
↗
November 10, 2025
Via
Stocktwits
Performance
More News
Read More
Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments
↗
November 03, 2025
Via
Stocktwits
Vor Bio Stock Jumped 19% Today And Retail Investors Are Eyeing A Breakout Rally: Here’s What’s Happening
↗
August 13, 2025
Via
Stocktwits
3 Top-Ranked ETFs Under $20 For Your Portfolio
↗
June 07, 2024
Via
Talk Markets
Topics
ETFs
5 Market-Beating Sector ETFs Of Q1
↗
March 27, 2024
Via
Talk Markets
Topics
ETFs
5 Sector ETFs Beating The Market Halfway Through Q1
↗
February 12, 2024
Via
Talk Markets
Topics
ETFs
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
↗
March 15, 2023
Via
InvestorPlace
5 Top-Ranked ETFs To Buy At Bargain Prices For 2023
↗
January 04, 2023
Via
Talk Markets
5 ETFs Riding High On The Biotech Comeback
↗
July 09, 2022
Via
Talk Markets
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
↗
June 14, 2021
Via
Talk Markets
Best Biotech Stocks & ETFs for mRNA, Gene Editing
↗
April 29, 2021
Via
Talk Markets
Frequently Asked Questions
Is Range Cancer Therapeutics ETF publicly traded?
Yes, Range Cancer Therapeutics ETF is publicly traded.
What exchange does Range Cancer Therapeutics ETF trade on?
Range Cancer Therapeutics ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Range Cancer Therapeutics ETF?
The ticker symbol for Range Cancer Therapeutics ETF is CNCR on the Nasdaq Stock Market
What is the current price of Range Cancer Therapeutics ETF?
The current price of Range Cancer Therapeutics ETF is 9.020
When was Range Cancer Therapeutics ETF last traded?
The last trade of Range Cancer Therapeutics ETF was at 05/27/25 04:15 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
